Abstract
Activation of intracellular signaling pathways involving p38 and p42/44 MAP kinases may contribute importantly to synaptic plasticity underlying spinal neuronal sensitization. Inhibitors of p38 or p42/44 pathways moderately attenuated responses of dorsal horn neurons evoked by mustard oil but not brush and alleviated the behavioral reflex sensitization seen following nerve injury. Activation of p38 and p42/44 MAP kinases in spinal cord ipsilateral to constriction injury was reduced by antagonists of NMDA, VPAC2 and NK2 (but not related) receptors, the glial inhibitor propentofylline and inhibitors of TNF-alpha. A VPAC2 receptor agonist enhanced p38 phosphorylation and caused behavioral reflex sensitization in naïve animals that could be blocked by co-administration of p38 inhibitor. Conversely, an NK2 receptor agonist activated p42/44 and caused behavioral sensitization that could be prevented by co-administration of p42/44 inhibitor. Thus, spinal p38 and p42/44 MAP kinases are activated in neuropathic pain states by mechanisms involving VPAC2, NK2, NMDA receptors and glial cytokine production.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Disease Models, Animal
-
Enzyme Activation / drug effects
-
Enzyme Activation / physiology
-
Enzyme Inhibitors / pharmacology
-
Inflammation Mediators / pharmacology
-
MAP Kinase Signaling System / drug effects
-
MAP Kinase Signaling System / physiology*
-
Male
-
Mitogen-Activated Protein Kinase 1 / drug effects
-
Mitogen-Activated Protein Kinase 1 / metabolism
-
Neuralgia / metabolism
-
Neuralgia / physiopathology
-
Neuroglia / drug effects
-
Neuroglia / metabolism*
-
Neuroprotective Agents / pharmacology
-
Peripheral Nerve Injuries
-
Peripheral Nerves / metabolism
-
Peripheral Nerves / physiopathology
-
Peripheral Nervous System Diseases / metabolism*
-
Peripheral Nervous System Diseases / physiopathology
-
Phosphorylation / drug effects
-
Physical Stimulation
-
Posterior Horn Cells / drug effects
-
Posterior Horn Cells / metabolism*
-
Rats
-
Rats, Wistar
-
Receptors, N-Methyl-D-Aspartate / drug effects
-
Receptors, N-Methyl-D-Aspartate / metabolism
-
Receptors, Neurokinin-2 / drug effects
-
Receptors, Neurokinin-2 / metabolism*
-
Receptors, Vasoactive Intestinal Peptide, Type II / drug effects
-
Receptors, Vasoactive Intestinal Peptide, Type II / metabolism*
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
-
Tumor Necrosis Factor-alpha / metabolism
-
Xanthines / pharmacology
-
p38 Mitogen-Activated Protein Kinases / drug effects
-
p38 Mitogen-Activated Protein Kinases / metabolism
Substances
-
Enzyme Inhibitors
-
Inflammation Mediators
-
Neuroprotective Agents
-
Receptors, N-Methyl-D-Aspartate
-
Receptors, Neurokinin-2
-
Receptors, Vasoactive Intestinal Peptide, Type II
-
Tumor Necrosis Factor-alpha
-
Xanthines
-
propentofylline
-
Mitogen-Activated Protein Kinase 1
-
p38 Mitogen-Activated Protein Kinases